CLOV
Clover Health·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 2
Consensus Rating "Strong Buy"
Ample Liquidity
High Gross Profit Margin
Significant Net Income Decline
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About CLOV
Clover Health Investments, Corp.
A company that provides Medicare Advantage insurance plans and operates as a direct contracting entity with the U.S. government
3401 Mallory Lane, Suite 210, Franklin, Tennessee 37067
--
Clover Health Investments, Corp. was incorporated in the Cayman Islands on October 18, 2019. The company's vision is to enable Medicare physicians to identify and manage chronic diseases early. The company's strategy is to improve care for Medicare beneficiaries, develop an extensive network of physicians, and provide technology to help empower physicians. The company's proprietary software platform, Clover Assistant, helps execute this strategy, enabling physicians to detect, identify and manage chronic diseases earlier.
Earnings Call
Q1/2025
Estimate EPS-0.07
Actual EPS0.05
Estimate Revenue466.93M
Actual Revenue462.33M
Counterpart Health's Q1 2025: Unraveling Contradictions in Revenue Forecasts, SG&A Strategies, and Market Positioning
May 07,2025 07:26
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS0.03
Actual EPS-0.02
Estimate Revenue468.30M
Actual Revenue477.62M
Clover Health's Q2 2025 Earnings Call: Unpacking Contradictions in Part D Trends, Cost Efficiency, and Growth Strategy
Aug 06,2025 11:40
Earnings Decrypt
Earnings Decrypt
Q3/2025
Estimate EPS0.02
Actual EPS-0.05
Estimate Revenue471.08M
Actual Revenue479.10M
Clover Health's Q3 2025 Earnings Call: Contradictions Emerge on Member Cost Trends, IRA Relief, and Counterpart Contributions
Nov 04,2025 10:28
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
CLOV has released its 2025 Q3 earnings. EPS was reported at -0.05, versus the expected 0.02, missing expectations. The chart below visualizes how CLOV has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
CLOV has released its 2025 Q3 earnings report, with revenue of 496.65M, reflecting a YoY change of 50.05%, and net profit of -24.38M, showing a YoY change of -166.27%. The Sankey diagram below clearly presents CLOV's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
